Schumer eyes more cannabis reforms after ‘historic’ marijuana rescheduling decision

Senate Majority Leader Chuck Schumer says he remains committed to even more cannabis reforms. The U.S. Drug Enforcement Administration announced it plans to reclassify marijuana to a less restrictive category called Schedule III. The decision falls short of marijuana legalization, a cause Schumer has long championed.

Pot stocks rally snuffed day after DEA marijuana rescheduling development

Consumer pot stocks rally snuffed day after DEA marijuana rescheduling development. U.S. Multi-state operators hardest hit are Ayr Wellness and Trulieve Cannabis. Canopy Growth is the worst performer, down 29%. Most Canadian cannabis licensed producers are also struggling.

OMB review of cannabis rescheduling could put measure at risk

White House Office of Management and Budget review of cannabis rescheduling could scuttle the reform. Review could take 70 days to complete. The DEA's likely reclassification of marijuana from a Class I to a Class III controlled substance could be delayed until after the election.

Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana

The DEA moved marijuana from Schedule I to Schedule III under the Controlled Substances Act. The DEA's decision aligns with a recommendation from the Department of Health and Human Services to reschedule cannabis. The cannabis sector saw a notable upswing on Tuesday after the announcement.

Mario Naric On Canada's Shakeout Phase

Pot stocks surge on news of cannabis rescheduling

Pot stocks surge on news of cannabis rescheduling. The DEA is set to reclassify marijuana as a less dangerous drug. U.S. Multi-state operators have recorded double-digit percentage gains. Cannabis-related stocks rose sharply higher in afternoon trading Tuesday.

US drug control agency to reschedule marijuana: AP

The DEA is set to reclassify marijuana as a less dangerous drug, the Associated Press reports. The drug is currently categorized under Schedule I alongside dangerous drugs like heroin and LSD. If approved, cannabis will be part of Schedule III, reserved for medications like ketamine and Tylenol.

Marijuana rescheduling decision is imminent, anti-cannabis group says

Healthcare Marijuana rescheduling decision is imminent, anti-cannabis group says. The DEA is set to announce the results of its ongoing cannabis scheduling review “very soon,” Smart Approaches to Marijuana says. A decision could move cannabis from Schedule I to Schedule III under the Controlled Substances Act.

Marijuana banking measure loses potential avenue to passage

An attempt to attach a measure allowing marijuana businesses to work with the U.S. Banking system to a must-pass aviation bill has been scuttled. The plan was to attach the Secure and Fair Enforcement Regulation Banking Act to the FAA's reauthorization bill. The cannabis council says the measure will not be included in the package.

Weekly Report: what happened at YOLO last week (0422-0426)?

Cannabis MSOs get date for oral arguments in federal marijuana law case

Federal judge in Massachusetts sets May 22 as the date for oral arguments in federal marijuana law case. Cannabis MSOs argue MSOs should be shielded from federal marijuana prohibition laws in states where the plant is legal. The key issue in the case is whether the federal government can interfere in cannabis businesses in legal states.

Cannabis stocks outperform as pressure mount on DEA to reschedule marijuana

Weekly Report: what happened at YOLO last week (0415-0419)?

On 4/20 Day, even non-cannabis companies get in the spirit

On eve of 4/20, White House and Democratic lawmaker tout marijuana progress

White House and Democratic lawmaker tout marijuana progress on eve of 4/20 Day. President Biden has promised to decriminalize marijuana on the federal level. The Justice Department is reviewing a recommendation to move marijuana from a Schedule I to a Schedule III drug. Rep. Earl Blumenauer says this is the last time cannabis will be on Schedule I.

Marijuana groups call on Biden to remove cannabis from Controlled Substances Act

Marijuana banking could pass House in must-pass bill - report

Marijuana banking unlikely to pass House due to Republican leadership spat

What's Going On With Cannabis Stocks Wednesday?

Several cannabis stocks are trending higher Wednesday afternoon. Wednesday marks the final day of Benzinga's Cannabis Capital Conference in Hollywood, Florida. Cannabis stocks are well off their lows for the day and trending higher in the afternoon. Sen. Jack Reed pressed Attorney General Merrick Garland about a bipartisan marijuana banking bill.

From Benzinga's Capital Cannabis Conference: Charlie Bachtell CEO At Cresco Labs Says The Cannabis Industry Needs Access To Capital To Be Able To Growth